Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Conditions
- Post-Acute COVID-19 Syndrome
- Postural Tachycardia Syndrome (POTS)
- SARS CoV 2 Infection
- Long COVID19
Interventions
- DRUG: To Measure levels of circulating monocyte/ T cell doublets at Baseline
- DRUG: To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment
- DRUG: To measure levels of circulating monocyte/ T cell doublets after 28 days of Placebo treatment
- DIAGNOSTIC_TEST: To Measure Splanchnic venous capacitance after 28 days of Treatment with 2HOBA
- DIAGNOSTIC_TEST: To Measure Splanchnic venous capacitance after 28 days of Treatment with Placebo
- DIAGNOSTIC_TEST: To Measure Orthostatic Tachycardia after 28 days of Treatment with 2HOBA
- DIAGNOSTIC_TEST: To Measure Orthostatic Tachycardia after 28 days of Treatment with Placebo
Sponsor
Vanderbilt University Medical Center
Collaborators